Neurosciences
ROCHESTER, Minn. — An international study led by Mayo Clinic researchers has identified interleukin-6 (IL-6) receptor blockers as a promising option for preventing relapses in[...]
Latest stories
Cancer
October 20, 2026
Research
October 15, 2026
Featured News
October 14, 2026
Cancer
October 14, 2026
Cancer
October 9, 2026
Cancer
October 6, 2026
Sign up to receive email notifications
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community